Prostate Forum of Orange County

Prostate Forum of Orange County, California is a 501(c)(3) organization 

Mailing Address

Prostate Forum of Orange County,CA

1519 East Chapman, #380

Fullerton, CA 92831

Meeting/Classes Location

The First Presbyterian Church of Fullerton

838 N. Euclid Street

Fullerton, CA 92832

Help Line: 1-714-459-2058

Email Us:  prostateforumoc@gmail.com 

For more information about our non-profit organization, meetings, prostate cancer information or to be added to our email mailing list to receive our monthly meetings bulletins, please submit your email above or send us a note at: prostateforumoc@gmail.com.

© 2019 Prostate Forum of Orange County

Past Speakers

Offering help and hope to men by providing prostate health information

The Prostate Forum of Orange County thanks our distinguished experts for their generous donation of their expertise and time. 

Page is in the process of being updated (as of March 27, 2019)

2019

Speaker: Allen Auerbach, MD

Date: March 28, 2019

Topic: 

Speaker: Albert Chang, MD

Date: January 24, 2019

Topic:

Speaker: Richard Lam, MD

Date: February 28, 2019

2018

Speaker: Fabio Almeida, MD, Phoenix Molecular Imaging, YMRC Cancer Center PET/CT
Date:   March 22, 2018 
Topic:  Imaging in Prostate Cancer 
Advanced imaging is becoming more important in the diagnosis and treatment of Prostate Cancer. Dr. Fabio Almeida will discuss the various options for imaging, from bone scans to newer methods such as C11-Acetate PET/CT and Gallium-68-PSMA PSMA. He will also discuss new radiotherapy options on the horizon.   BIO

(Previous presentation:February 25, 2016 , subject: Carbon -11 Acetate PET/CT Imaging of the Prostate - an update.)

Speaker: Tanya Dorff, MD

Date: July 26, 2018

Topic:

 

Speaker:  Leonard A. Farber, MD, City Hope, St. Joseph Health/St. Jude Medical Center 
Date: October 25, 2018
Topic: Advances in radiation therapy for prostate cancer: SBRT (Stereotactic Body Radiotherapy)  Fractionation options in RT for prostate cancer, Physician perspective, Patient perspective, Modality comparisons, SBRT techniques and technical considerations.  BIO

Speaker: Mitchell Kamrava, MD,

Date: February 22, 2018

Topic: 

Speaker:  Dong Won Kim, MD, PhD, Kaiser
Date:  November 15, 2018
Topic: Pro/Cons in Deploying IMRT, SBRT and Seeds in Prostate Cancer
Radiation oncologist.  BIO

Speaker:  David Krasne, MD, Pacific Neuroscience Institute, Pathologist 
Date:  September 27, 2018
Topic:  Pathology of Prostate Cancer in 2018. Importance of Tumor Grade and Other nuances Key to Understanding a Biopsy Report.

Today in no other human cancer are clinical management decisions so heavily based on the cancer histologic grade as determined by a pathologist.  The main topics are: Review the spectrum of clinical behavior of prostate cancer. Treatment benefits for low, intermediate and high- risk prostate cancers and how critically tumor grade guides decisions to treat, actively monitor or observe a cancer.  What is cancer grade and how do pathologists assign prostate cancer grades. What are some of the problem areas prone to subjective interpretive differences among pathologists and diagnostic errors. When obtaining a second or expert opinion may be indicated,  BIO

 

Speaker: Richard Lam, MD, Director Clinical Research Prostate Oncology Specialists
Date:  January 28, 2018
Topic: Hormone Refractory Prostate Cancer
Dr. Lam has written numerous articles based on his research. He is an active member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Lam continues to promote prostate cancer awareness and education by giving lectures at various medical conferences and prostate support groups throughout the country. He is particularly interested in utilizing state-of-the-art therapeutics for advanced prostate cancer.   BIO

Speaker: Thomas K. Lee, MD, Ph.D, Associate Clinical Professor, Univ. Irvine School of Medicine 
Date:May 24, 2018
Topic: Understanding the details in your pathology report: Biopsy vs. Radical Prostatectomy
Presentation topics:  Describe the evolution and meaning of the Gleason Score. Explain the new grading system for prostate cancer, piggy backing on the Gleason Score. How do the information in the biopsy report guide treatment? What are the key items in the radical prostatectomy report?  BIO

Speaker: Robert Pugach, MD, Medical Director Western State HIFU 
Date:  June 28, 2018 
Topic:  Focal and Whole Gland HIFU - The Gold Standard for Low-Intermediate Risk Prostate Cancer
What you need to know about recurrent prostate cancer.  What is Focal and Whole Gland HIFU.
Why HIFU is the Gold Standard for Low-Intermediate Risk Prostate Cancer. Update on the Reversal by the US Preventative Task Force recommendations on their original guidance on prostate cancer screening. BIO    www.hifuprostatecancermd.com  

Speaker: Mark Scholz, MD, Prostate Oncology Specialists 
Date:  April 26, 2018 
Topic: Five Stages of Prostate Cancer
Presentation topics:  Five major stages and 15 subtypes of Prostate Cancer. Life threatening vs. benign Prostate Cancer. Receiving optimal therapy depends on matching an appropriate treatment with correct stage and type of  Prostate Cancer. BIO

Dr. Scholz has been guest speaker at the Prostate Forum on September 22, 2016, April 23, 2015, September 26, 2013 and June 28, 2012.

Speaker: Jane Shellhouse, nutrionist

Date: August 23, 2018 

Topic:


2017

Speaker:  Arnold I. Chin, MD, Ph.D., Urologist and Assistant Professor UCLA 

Date: April 27, 2017 

Topic:  Robotic Assisted Laparoscopic Radical Prostatectomy

Preoperative evaluation including use of MRI in biopsies and surgical planning.  Illustrate surgical techniques with video excerpts.  Postoperative surveillance including use of novel PET-imaging for biochemical PSA recurrence. BIO

 

Speaker: Donald B. Fuller, MD, Genesis Healthcare

Date: October 26, 2017

Topic:  Treating Prostate Cancer with Radiation Therapy with emphasis on IMRT (including Calypso), or Cyber Knife. BIO

 

Speaker: Heather C. Lamb, Manager Onc. Business Development, NeoGenomics Laboratories ,Inc.,

Date:  August 24, 2017

Topic:  Liquid Biopsy and its Role in Today's Cancer Treatments

Discussion of what a Liquid Biopsy is and how it is currently being used by physicians. How is liquid biopsy impacting cancer treatment? Bio-markers relevant to Prostate Cancer. Actual patients' case presentations. 
 

Speaker:  Carl Rossi, MD, Scripps 

Date: January 26, 2017

Dr.  Rossi is a radiation oncologist specializing in proton beam therapy, specifically for prostate cancer and lymphomas. He is also the current medical director for the Scripps Proton Therapy Center, which will provide treatment to target tumors with high control and precision. In addition to treating a variety of cancers with radiation, it is also used to treat some non-cancerous conditions.  Dr. Rossi has a research focus on the quality of life and cure rate in prostate cancer and lymphoma treated with proton beam radiation.  BIO 

2016

Speaker: Jeffrey Demanes, MD, FACRO, FACR, FASTRO
Date:  April 28, 2016
Topic: Dr. Demanes specializes in brachytherapy, the surgical subspecialty of radiation oncology. He founded the California Endocurietherapy Center (CET) in 1981 and has performed more than 10,000 surgical radiation implants.  BIO

Speaker: Ashod J. Kar, MD, St. Joseph’s Hospital 
Date:   March 31, 2016
Topic: Robotic Surgery or HIFU…which one is best for me? 

Traditionally, prostate cancer is treated with surgery, radiation or both. The most common form of surgery is a robotic prostatectomy using a surgical robot. Today, over 80 percent of prostatectomies performed in the U.S. are done using the DaVinci robotics.  In recent years, a new technology has been introduced to treat prostate cancer without radiation or surgical incisions called High Intensity Focused Ultrasound (HIFU), now approved and used in over 39 countries. This procedure is a revolutionary form of therapy for organ-confined disease with its ability to produce the same results as a surgical or radiation procedure without the long-term effects. These cases are done in a single session, on an out-patient basis.  BIO  

Speaker: Paul J. Kim, MD, Hoag Hospital 
Date: May 26, 2016 
Dr. Kim is a board certified radiation oncologist and is the Medical Director of  Skyline Radiation Oncology, in Tustin, California. Dr. Paul J. Kim is a Southern California native who graduated with honors from Stanford University. He obtained his medical degree from Yale University School of Medicine.  BIO

Speaker: Gary E. Leach, MD, Tower Urology 
Date: June 23, 2016 
Topic: The Latest and Greatest Technologies in Erectile Dysfunction and Male Urinary Incontinence
Dr. Leach will update us on the latest and greatest technologies in Erectile Dysfunction and Male Urinary Incontinence.  Dr. Leach has written over 100 scientific articles related to Urology.  BIO

  

We Need Your Support Today!